dc.contributor.authors |
Solak, B; Karkucak, M; Turan, H; Ocakoglu, G; Sag, SO; Uslu, E; Yakut, T; Erdem, T; |
|
dc.date.accessioned |
2020-02-27T08:48:57Z |
|
dc.date.available |
2020-02-27T08:48:57Z |
|
dc.date.issued |
2016 |
|
dc.identifier.citation |
Solak, B; Karkucak, M; Turan, H; Ocakoglu, G; Sag, SO; Uslu, E; Yakut, T; Erdem, T; (2016). Glutathione S-Transferase M1 and T1 Gene Polymorphisms in Patients with Chronic Plaque-Type Psoriasis: A Case-Control Study. MEDICAL PRINCIPLES AND PRACTICE, 25, 158-155 |
|
dc.identifier.issn |
1011-7571 |
|
dc.identifier.uri |
https://doi.org/10.1159/000442165 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/66951 |
|
dc.description.abstract |
Objective: To determine the role of glutathione S-transferase (GST) isoenzyme polymorphisms as susceptibility factors in patients with psoriasis in a Turkish cohort. Subjects and Methods: In this case-control study, 105 patients with plaque-type psoriasis and 102 healthy controls were recruited from the dermatology outpatient clinics of two university hospitals. Genomic DNA was extracted from whole blood using a DZ DNA isolation kit. Multiplex PCR was used to determine GSTM1 and GSTT1 polymorphisms in the isolated DNAs. Results: Of the 150 patients with psoriasis, 83 (79%) were identified with the GSTT1 genotype and 22 (21%) with the null genotype. Of the 102 patients in the control group, 69 (67.6%) subjects were identified with the GSTT1 genotype and 33 (32.4%) with the null genotype. There was no significant difference between the patient and control groups (p = 0.063). Regarding the GSTM1 polymorphism, 54 (51.4%) patients were identified with this genotype and 51 (48.6%) with the null genotype; in the control group, 50 (49%) were identified with this genotype and 52 (51%) with the null genotype. Again there was no statistically significant difference between the groups (p = 0.957). Conclusion: In this Turkish cohort of patients with psoriasis, neither GSTT1 nor GSTM1 polymorphisms were associated with disease susceptibility. Larger studies with a wider range of GST isoenzyme are needed. (C) 2015 S. Karger AG, Basel |
|
dc.language |
English |
|
dc.publisher |
KARGER |
|
dc.subject |
General & Internal Medicine |
|
dc.title |
Glutathione S-Transferase M1 and T1 Gene Polymorphisms in Patients with Chronic Plaque-Type Psoriasis: A Case-Control Study |
|
dc.type |
Article |
|
dc.identifier.volume |
25 |
|
dc.identifier.startpage |
155 |
|
dc.identifier.endpage |
158 |
|
dc.contributor.department |
Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü |
|
dc.contributor.saüauthor |
Solak, Berna |
|
dc.relation.journal |
MEDICAL PRINCIPLES AND PRACTICE |
|
dc.identifier.wos |
WOS:000370081000009 |
|
dc.identifier.doi |
10.1159/000442165 |
|
dc.identifier.eissn |
1423-0151 |
|
dc.contributor.author |
Solak, Berna |
|
dc.contributor.author |
Mutlu Karkucak |
|
dc.contributor.author |
Hakan Turan |
|
dc.contributor.author |
Gokhan Ocakoglu |
|
dc.contributor.author |
Sebnem Ozemri Sag |
|
dc.contributor.author |
Esma Uslu |
|
dc.contributor.author |
Tahsin Yakut |
|
dc.contributor.author |
Teoman Erdem |
|